News & Views
Welcome to our blog! You will find a wealth of information whether it is news, opinion, presentations, articles and videos from us or relevant shared content. This might be about the pharma and healthcare industry, our projects, marketing, therapy areas – we hope to keep you thinking and ahead of the curve.
“SHIFT LEFT”: Mitigating Against Supply Chain Delay / Interruption
"SHIFT LEFT": Our Managing Director is joined by OneSC CEO and Founder, Jitesh Halai. They discuss mitigating against supply chain delay and interruption.
“SHIFT RIGHT”: The Where & Why of Supply Delay / Interruption
"SHIFT RIGHT": The Where and Why of Supply Delay / Interruption. Part 2 of a 3 part series where we dive into batch delays …
“SHIFT RIGHT”: The Challenges of Supply Delay / Interruption and Forecasting
"SHIFT RIGHT": The Challenges of Supply Delay / Interruption and forecasting. Part 1 of a 3 part series. In part 1, we look at …
“Rapid Fire Q&A”, WOMEN’S HEALTH, Part 3 of 3 Vlogs
"Rapid Fire Q&A" on WOMEN'S HEALTH. This is the final part, number 3 of 3 video interviews with our Managing Director, David Browne. We …
“Rapid Fire Q&A”, WOMEN’S HEALTH, Part 2 of 3 Vlogs
"Rapid Fire Q&A" on WOMEN'S HEALTH. This is part 2 of 3 video interviews with our Managing Director, David Browne. We cover consumers, choice, …
“Rapid Fire Q&A”, WOMEN’S HEALTH, Part 1 of 3 Vlogs
"Rapid Fire Q&A" on WOMEN'S HEALTH. This is part 1 of 3 video interviews with our Managing Director, David Browne. We cover experience, definitions …
Compliance, Speed Limits and Reputation!
Compliance is key: not only for avoiding complaints but for building trust and reputation with HCPs who hold the trust of their patients.
Category H introduction …. the end of branded generics in the UK?
Category H introduction has been announced although detail is lacking. It will undoubtedly affect branded generics and this article gives an outline as to …
Insight: the bedrock of any good plan … but KISS!
Insight is the bedrock of any good plan or business decision. Make sure you KISS (Keep It Simple Stupid) and focus on the data …
Established molecules – more than “just” generics?
A frequent response to hearing the words “established molecules” is “so you mean generics, right?” Well yes, and no! There is more to it …
OMD: Fractional, interim support from Hawk Pharma Consulting
We are delighted to add OMD, Our Marketing Department, to the offering from Hawk Pharma Consulting. Our fractional, interim marketing resource offering will help …
Testimonial – the Hawk Pharma Consulting difference!
“As Managing Director & Consultancy Lead it is hugely rewarding when a client takes time out of their busy day to write a testimonial …
Environmental Footprint part 2 – Getting started!
In most parts of Europe the pressure is on with regard to carbon and moving towards net zero. This is no longer a “nice-to-do” …
Environmental Footprint & Sustainability – explained simply!
The NHS has the target of being carbon net zero by 2040 and, as the customer of all UK-based pharma companies, the industry must …
Education and Strategic Marketing
4th June 2024 saw the EMIG HR group meet and our Managing Director & Lead Consultant, David Browne, present having been invited by the …
Digital Transformation and Omnichannel
As Consultants it is important to be up to date with not just the latest movements but also market changes that could be predicted …